Scientist I – Content Development
TLDR
Support the development and optimization of innovative multiplex proteomic panels to enable early disease detection, collaborating with cross-functional teams for high-quality deliverables.
At Alamar, we are passionate about enabling our customers to make scientific discoveries that translate into clinical outcomes and benefit patients. Our team is growing quickly as we develop innovative approaches to measure critical protein biomarkers from liquid samples that can enable the earliest possible detection of disease. We believe the next frontier in biology is enabled by measuring proteins at higher sensitivity in highly multiplexed assays at the push of a button, which is something only Alamar can do. As we build our team, we seek collaborative, driven, intellectually curious people committed to solving complex challenges. Our culture rewards accountability and cross functional teamwork because we believe this enables the kind of breakthrough thinking that will accelerate our mission.
Position Summary
We are seeking a highly motivated Scientist I to join the Content Development team. In this role, you will support the development, optimization, and characterization of NULISA-based immunoassays and multiplex proteomic panels across diverse disease areas. You will work closely with cross-functional partners including R&D, Manufacturing, Bioinformatics, and related teams to ensure robust assay performance and high-quality deliverables.
The ideal candidate will bring strong hands-on immunoassay execution skills, a solid foundation in data analysis, and the ability to contribute effectively in a fast-paced, collaborative product development environment.
Duties and Responsibilities
- Design, development, and optimization of multiplex proteomic panels across various disease areas to support biomarker discovery, validation, and translational research.
- Develop and optimize the high-plex panels to ensure high specificity, sensitivity, and reproducibility of the product.
- Perform multivariate analysis to optimize assay performance, minimize cross-reactivity and mitigate matrix effect.
- Troubleshoot technical challenges via root-cause analysis and implement corrective strategies.
- Develop and maintain critical documentation, including SOPs, PRDs, and assay transfer documents to support product development and regulatory compliance.
- Collaborate cross-functionally to advance projects and contribute to strategic discussions.
Qualifications
- Ph.D. in Biochemistry, Molecular Biology, or a related discipline with 0–3 years of relevant industry experience; M.S. with 2–5 years of experience will also be considered.
- Hands-on experience with immunoassays or multiplex assay platforms (e.g., Luminex, MSD, Olink, Ella, SomaLogic, etc.).
- Familiarity with molecular biology methods (e.g., qPCR, ddPCR, or NGS) is a plus.
- Strong problem-solving and analytical skills with attention to detail in experimental execution.
- Ability to manage time effectively, work collaboratively, and adapt in a fast-paced environment.
- Strong communication skills, including data presentation and technical documentation.
- Knowledge of biomarker research, assay validation, or clinical sample testing is desirable.
The base salary range for this full-time position is $120,000 - $140,000 + bonus + equity + benefits. Our salary ranges are determined by work location, job-related skills, experience, and relevant education or training. The ranges displayed on each job posting reflect the minimum and maximum target for new hire salaries but are subject to change if the leveling of the role is adjusted. Your recruiter can share more about the specific salary range during the hiring process.
Alamar Biosciences builds cutting-edge solutions to measure critical protein biomarkers from liquid samples, facilitating early disease detection. Our technology enables scientists and researchers to make rapid and impactful discoveries that translate into real clinical outcomes for patients. What sets us apart is our ability to achieve higher sensitivity in highly multiplexed assays, redefining the possibilities in biomarker measurement.